Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Balance at Dec. 31, 2022	$ 176,600	$ 2	$ 288,814	$ (112,216)
Balance (in Shares) at Dec. 31, 2022		17,403,315
Issuance of common stock upon exercise of stock options	1,067		1,067
Issuance of common stock upon exercise of stock options (in Shares)		74,753
Vesting of restricted common stock (in Shares)		958
Stock-based compensation expense	1,024		1,024
Sale of common stock in registered direct offering	34,148		34,148
Sale of common stock in registered direct offering, (in shares)		1,488,166
Sale of pre-funded warrants in registered direct offering	28,206		28,206
Sale of common stock in at-the-market offerings	14,591		14,591
Sale of common stock in at-the-market offerings, (in shares)		608,050
Net Income (Loss)	(22,781)			(22,781)
Balance at Mar. 31, 2023	232,855	$ 2	367,850	(134,997)
Balance (in Shares) at Mar. 31, 2023		19,575,242
Balance at Dec. 31, 2023	345,121	$ 2	533,764	(188,645)
Balance (in Shares) at Dec. 31, 2023		24,360,233
Issuance of common stock upon exercise of stock options	$ 806		806
Issuance of common stock upon exercise of stock options (in Shares)	95,467	95,467
Stock-based compensation expense	$ 4,058		4,058
Sale of common stock in at-the-market offerings	14,790		14,790
Sale of common stock in at-the-market offerings, (in shares)		234,449
Issuance of common stock under employee stock purchase plan	245		245
Issuance of common stock under employee stock purchase plan (in shares)		5,736
Net Income (Loss)	(26,949)			(26,949)
Balance at Mar. 31, 2024	$ 338,071	$ 2	$ 553,663	$ (215,594)
Balance (in Shares) at Mar. 31, 2024		24,695,885